Cancer Therapy Advisor (10/19, Lawrence) reported, “Changes in weight or body mass index (BMI) around the time of endometrial cancer diagnosis are associated with reduced survival, according to a study published in JNCI: Journal of the National Cancer Institute.” The study “showed that patients with a 5% or greater gain or loss in weight or BMI from 1 […]
Medscape (10/13, Stern, Subscription Publication) reported, “The US Food and Drug Administration (FDA) has approved the checkpoint inhibitor pembrolizumab…alongside standard chemotherapy — with or without bevacizumab — as first-line therapy for patients with persistent, recurrent, or metastatic PD-L1-expressing cervical cancer.” The agency “also announced the regular approval of pembrolizumab alone for patients with recurrent or metastatic […]
Newsweek (9/28, Sulleyman) reported on the efforts of Kari Neumayer to raise “awareness of ovarian cancer and how difficult it can be to detect, having been diagnosed with the illness by a dermatologist who removed a small growth from her navel.” Writing on HuffPost about her experience, Neumayer “said the growth inside her navel was, at […]